Alyeska Investment Group’s Aptevo Therapeutics APVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Hold |
0
| – | – | – | 443 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 436 |
|
|
2021
Q3 | – | Sell |
-4
| Closed | -$3.12M | – | 680 |
|
|
2021
Q2 | $3.12M | Buy |
4
+1
| +33% | +$781K | 0.04% | 434 |
|
|
2021
Q1 | $2.64M | Buy |
3
+1
| +50% | +$880K | 0.03% | 414 |
|
|
2020
Q4 | $1.82M | Buy |
+2
| New | +$1.82M | 0.03% | 372 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 456 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 448 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 346 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 369 |
|
|
2019
Q3 | – | Sell |
-1
| Closed | -$207K | – | 361 |
|
|
2019
Q2 | $207K | Sell |
1
-1
| -50% | -$207K | ﹤0.01% | 378 |
|
|
2019
Q1 | $631K | Buy |
+2
| New | +$631K | 0.01% | 296 |
|